EE136 Cost-Effectiveness Analysis of Tisagenlecleucel Using Long-Term Survival Outcomes in Treating Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma from US Societal Perspective
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.386
https://www.valueinhealthjournal.com/article/S1098-3015(22)00587-3/fulltext
Title :
EE136 Cost-Effectiveness Analysis of Tisagenlecleucel Using Long-Term Survival Outcomes in Treating Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma from US Societal Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00587-3&doi=10.1016/j.jval.2022.04.386
First page :
Section Title :
Open access? :
No
Section Order :
10343